Key regions: China, South Korea, Japan, Canada, India
The Wound Care (Pharmacies) market in G20 is witnessing significant growth and development due to various factors.
Customer preferences: Customers in the Wound Care (Pharmacies) market in G20 are increasingly seeking products that offer effective and efficient wound healing solutions. They prefer products that are easy to use, have minimal side effects, and provide quick relief. Additionally, customers are also looking for wound care products that are affordable and easily accessible at local pharmacies.
Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in G20 is the increasing demand for advanced wound care products. This can be attributed to the rising prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, which require specialized treatment. Advanced wound care products, such as dressings, gels, and wound closure devices, are designed to promote faster healing and reduce the risk of infection. Another trend in the market is the growing adoption of telemedicine and e-commerce platforms for wound care products. With the increasing use of smartphones and internet penetration, customers are now able to consult healthcare professionals online and purchase wound care products from the comfort of their homes. This convenience factor has significantly contributed to the growth of the online wound care market in G20.
Local special circumstances: The development of the Wound Care (Pharmacies) market in G20 is also influenced by local special circumstances. For example, in countries with aging populations, such as Japan and Germany, there is a higher demand for wound care products due to the increased prevalence of chronic wounds. Similarly, in countries with a high incidence of diabetes, such as India and Mexico, there is a greater need for wound care products to manage diabetic ulcers.
Underlying macroeconomic factors: The growth of the Wound Care (Pharmacies) market in G20 is also driven by underlying macroeconomic factors. For instance, the increasing healthcare expenditure in G20 countries is leading to higher investments in healthcare infrastructure, including pharmacies. This, in turn, is boosting the availability and accessibility of wound care products. Furthermore, the rising disposable income in G20 countries is enabling customers to afford premium wound care products, which are often priced higher than conventional wound care products. The growing middle-class population in G20 countries is also contributing to the increasing demand for wound care products. In conclusion, the Wound Care (Pharmacies) market in G20 is experiencing growth and development due to customer preferences for effective and affordable wound care products, the increasing demand for advanced wound care solutions, the adoption of telemedicine and e-commerce platforms, local special circumstances, and underlying macroeconomic factors such as healthcare expenditure and rising disposable income.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
